Oxford Biomedica plc (OXB) Ordinary 50p
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
340.00p
342.50p
460.00p
£358.03 million
343.00p
336.00p
164.40p
n/a
3.00p (0.88%) Previous:
3.00p
163,630
n/a
3,000
Performance
1 week 1W | 4.41% | 1 year 1Y | 19.86% |
---|---|---|---|
1 month 1M | 11.91% | 2 years 2Y | 22.83% |
3 months 3M | 75.72% | 3 years 3Y | 73.78% |
6 months 6M | 82.06% | 5 years 5Y | 50.22% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 89.54 | 139.99 |
Profit before tax (£m) | (188.53) | (45.98) |
Adjusted EPS (p): | (163.11) | (41.29) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Oxford Biomedica appoints new finance chief
17 July 2024 09:51
-
Oxford Biomedica confident as it moves away from vaccine era
29 April 2024 08:09
-
Oxford Biomedica shares rise on post-acquisition guidance
5 March 2024 16:22
-
OXB announces CFO transition
17 July 2024 07:00
-
Person Closely Associated Dealing
3 July 2024 09:19
-
BLOCK LISTING RETURN
1 July 2024 11:24
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.